NCT05133687View on ClinicalTrials.gov

The Hemodynamic Effects of Different Volumes of Bupivacaine 0.25% Caudal Blocks in Pediatrics Undergoing Lower Abdominal Surgeries as Measured by Electrical Cardiometry

PHASE3CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions
Anesthesia, CaudalPediatrics
Interventions
DRUG

Bupivacaine Hydrochloride

Recruited children will be randomly assigned to one of three groups in a 1:1:1 ratio; (Group 0.8-G), (Group 1.2-G) and (Group G).

Trial Locations (1)

11559

Cairo university hospitals, kasralainy, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT05133687 - The Hemodynamic Effects of Different Volumes of Bupivacaine 0.25% Caudal Blocks in Pediatrics Undergoing Lower Abdominal Surgeries as Measured by Electrical Cardiometry | Biotech Hunter | Biotech Hunter